Hopp til innhold

Gunhild Hagen

Senior Adviser 46400429 e-mail Send e-mail

Publications

Year Title Type
2013 Efficacy and cost-effectiveness of new oral anticoagulants compared to warfarin for the prevention of stroke in patients with atrial fibrillation Report from NOKC
2012 Early ultrasound in routine pregnancy care Memorandum
2011 Health economic evaluation of thromboprophylactic treatment with rivaroxaban or dabigatran compared with enoxaparin in patients undergoing elective hip- or knee replacement surgery
2011 Thromboprophylactic treatment with rivaroxaban or dabigatran compared with enoxaparin or dalteparin in patients undergoing elective hip- or knee replacement surgery Report from NOKC
2011 Efficacy and cost-effectiveness of alendronate for the prevention of fractures in postmenopausal women in Norway Report from NOKC
2011 Biologics for early rheumatoid arthritis: Review of health economic studies Report from NOKC
2010 Incorporating Quality of Eefficacy Documentation in Health Economic Evaluations - Does It Matter?
2010 Cost-effectiveness of Drugs for Smoking Cessation in Norway
2010 Relative efficacy, safety and cost-effectiveness of nicotine replacement therapy, bupropion and varenicline for smoking cessation in Norway
2010 Cost-effectiveness of varenicline, bupropion and nicotine replacement therapy for smoking cessation Report from NOKC
2010 Drugs for smoking cessation Report from NOKC
2009 Cost-effectiveness of childhood vaccination against rotavirus in Norway Report from NOKC
2008 Comparison of palonosetron with ondansetron, with respect to clinical efficacy and cost effectiveness in the prevention of chemotherapy induced nausea and vomiting in cancer patients Report from NOKC

Print

Gunhild_Hagen

Gunhild Hagen
Health Economics and Drugs Unit

EDUCATION

B.A. Health Management and Health Economics, M.Phil. Health Economics, Policy and Management

PROJECTS